# Alnylam Pharmaceuticals Inc (ALNY) — Net Income

## Annual Net Income (USD)

| Year | Net Income |
| --- | --- |
| 2025 | $314M |
| 2024 | -$278M |
| 2023 | -$440M |
| 2022 | -$1.13B |
| 2021 | -$853M |
| 2020 | -$858M |
| 2019 | -$886M |
| 2018 | -$761M |
| 2017 | -$491M |
| 2016 | -$410M |
| 2010 | -$44M |
| 2009 | -$48M |
| 2008 | -$26M |

## Quarterly Net Income (USD)

| Quarter | Net Income |
| --- | --- |
| 2025-09-30 | $251M |
| 2025-06-30 | -$66M |
| 2025-03-31 | -$57M |
| 2024-09-30 | -$112M |
| 2024-06-30 | -$17M |
| 2024-03-31 | -$66M |
| 2023-09-30 | $148M |
| 2023-06-30 | -$276M |
| 2023-03-31 | -$174M |
| 2022-09-30 | -$406M |
| 2022-06-30 | -$277M |
| 2022-03-31 | -$240M |
| 2021-09-30 | -$205M |
| 2021-06-30 | -$190M |
| 2021-03-31 | -$200M |
| 2020-09-30 | -$253M |
| 2020-06-30 | -$179M |
| 2020-03-31 | -$182M |
| 2019-09-30 | -$209M |
| 2019-06-30 | -$219M |
| 2019-03-31 | -$182M |
| 2018-09-30 | -$245M |
| 2018-06-30 | -$164M |
| 2018-03-31 | -$141M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ALNY/net-income)